Web Results

www.pacermonitor.com/public/case/22663240/Rivera_v_Sanofi_SA_et_al

Oct 5, 2017 ... Rivera v. Sanofi S.A. et al (2:17-cv-10170), Louisiana Eastern District Court, Filed : 10/05/2017 - PacerMonitor Mobile Federal and Bankruptcy ...

www.pacermonitor.com/public/case/22676026/Cheshier_v_Sanofi_SA_et_al

Oct 6, 2017 ... Cheshier v. Sanofi S.A. et al (2:17-cv-10217), Louisiana Eastern District Court, Filed: 10/06/2017 - PacerMonitor Mobile Federal and ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC1617062

Feb 27, 2006 ... A recent study (Jorda et al., 2004) showed that CB2 was ..... Apparently, an opposite regulation of CB1 expression in transformed versus normal cells was a ... Several authors (Rak et al., 1995; Casanova et al., 2002) suggested that ..... and Sanofi-Aventis Research for supporting our studies on this subject.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4697413

Dec 14, 2015 ... Six years later, Casanova laid bare the genetic basis of Devainon's immune deficiency in punctilious detail. ..... Ciancanelli MJ, et al. Infectious ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC4903998

Jun 13, 2016 ... Using whole genome sequencing, van Schouwenburg et al. recently ... and Merck, and personal fees from Genentech, Sanofi, Novartis, Pfizer, Bioaster, ... Picard C, Al-Herz W, Bousfiha A, Casanova J-L, Chatila T, Conley ME, et al. .... Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3710468

Jul 11, 2013 ... However, Bagnato et al. followed the evolution of serum β2MG in untreated .... to patients reporting any AE vs. those non reporting AEs (see Table 1). ... Merck Serono, Novartis, Bayer, Teva and Gemzime Sanofi Aventis. ... Bonaventura Casanova, Honoraria from Merck, Sanofi, Teva, Roche and Novartis.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4062420

Jun 18, 2014 ... Progression of retinopathy with intensive versus conventional treatment in .... Haan M, Espeland MA, Klein BE, Casanova R, Gaussoin SA, et al.

journals.plos.org/plosone/article?id=10.1371/journal.pone.0098587

Jun 18, 2014 ... Progression of retinopathy with intensive versus conventional treatment in .... Haan M, Espeland MA, Klein BE, Casanova R, Gaussoin SA, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3791996

Sep 17, 2013 ... A modification of the methyl-accepting assay (Broday et al., 1999) was used to ..... in the DNA of differentiated versus undifferentiated cells (Veres et al., 1989). .... [ PubMed]; Casanova ML, Blázquez C, Martínez-Palacio J, .... [PubMed]; Jones NA , Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, et al.